@article{JTD14170,
author = {Orlando Santana and Steve Xydas and Roy F. Williams and Angelo La Pietra and Maurice Mawad and Vicente Behrens and Esteban Escolar and Christos G. Mihos},
title = {Aortic valve replacement in patients with a left ventricular ejection fraction ≤35% performed via a minimally invasive right thoracotomy},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {Suppl 7},
year = {2017},
keywords = {},
abstract = {Background: We evaluated the outcomes of patients with aortic valve pathology in the setting of a left ventricular ejection fraction ≤35% who underwent minimally invasive aortic valve replacement (AVR), with or without concomitant mitral valve (MV) surgery.
Methods: All minimally invasive AVR in patients with a left ventricular ejection fraction ≤35%, performed via a right thoracotomy for aortic stenosis or regurgitation between January 2009 and March 2013, were retrospectively evaluated. The operative characteristics, perioperative outcomes, and 30-day mortality were analyzed.
Results: There were 75 patients identified: 51 who underwent isolated AVR, and 24 who had combined AVR plus MV surgery for moderate to severe mitral regurgitation. In patients undergoing MV surgery, there were 22 (91.7%) MV repairs [ring annuloplasty =7 (37.5%), transaortic edge-to-edge repair =15 (62.5%)], and 2 (8.3%) replacements. No patient required conversion to sternotomy for inadequate surgical field exposure. The median total mechanical ventilation time and intensive care unit length of stay were 14 (IQR, 8–20) and 42 hours (IQR, 26–93 hours) in the isolated AVR group, and 16.5 hours (IQR, 12–61.5 hours) and 95.5 hours (IQR, 43.5–159 hours) in the AVR plus MV surgery group, respectively. The most common post-operative complication was new-onset atrial fibrillation, which occurred in 15 (29.4%) isolated AVR and 4 (16.7%) AVR plus MV surgery patients. The median hospital length of stay and 30-day mortality was 7 days (IQR, 5–12 days) and 1 (2%) in the isolated AVR group, and 10.5 days (IQR, 5–21 days) and 1 (4.3%) for AVR plus MV surgery.
Conclusions: In patients with aortic valve pathology in the setting of a left ventricular ejection fraction ≤35%, minimally invasive AVR can be performed, with or without concomitant MV surgery, with a low morbidity and mortality.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/14170}
}